Strikingly, most of the top 14 differential methylation signals in our study appear to be influenced by genetic variants located near to these sites, suggesting that there is genetic variation between those with and without CKD in APOL1 high-risk genotypes. The gene discussed is APOL1; the disease is chronic kidney disease.